Disruption of the E1 and E2 reading frames of HPV 16 in cervical carcinoma is associated with poor prognosis

International Journal of Gynecological Pathology

Volumn 17, Issue 2, 1998, Pages 146-153

  Kalantari, Mina ^a   Karlsen, Frank ^b   Kristensen, Gunnar ^b   Holm, Ruth ^b   Hagmar, Bjorn ^b   Johansson, Bo ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Cervical cancer; Deletion; Disruption; E2; El; HPV 16; Integration; PCR

Indexed keywords

ADULT; AGED; ARTICLE; FEMALE; GENE AMPLIFICATION; GENE DELETION; GENE DISRUPTION; GENE MAPPING; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA; VIRUS CARCINOGENESIS; VIRUS GENE; WART VIRUS;

EID: 0031898931     PISSN: 02771691     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004347-199804000-00009     Document Type: Article

References (54)

1. Dürst M, Kleinheinz M, Hotz M. The physical state of human papillomavirus type 16 DNA in benign and malignant genital tumors. J Gen Virol 1985;66:1515-22.
2. zur Hausen H, Schnider A. The Papovaviridae: the role of papillomaviruses in human anogenital cancer. In: Salzman NP, Howley PM (eds). The Papoviridae. New York: Plenum Press 1987:245-63.
3. Karlsen F, Kristensen G, Holm R, Chitemerere M, Hagmar B. High incidence of human papillomavirus in 146 cervical carcinoma PCR-probe analysis of 146 cervical carcinoma. A study using three different human papillomavirus consensus primers, and detecting viral genome with putative deletions. Eur J Cancer 1995; 31A:1511-16.
4. Das BC, Sharma JK, Gopalakrishna V, Usha LK. Analysis by polymerase chain reaction of the physical state of human papillomavirus type 16 DNA in cervical preneoplastic and neoplastic lesions. J Gen Virol 1992;73:2327-36.
5. Lehn H, Villa LL, Marziona F, Hilgrath M, Hillemans HG, Sauer G. Physical state and biological activity of human papillomavirus genomes in precancerous lesions of the female genital tract. J Gen Virol 1988;69:187-96.
6. Berumen J, Casas L, Segura E, Amezcua JL, Garcia-Carranca A. Genome amplication of Human papillomaviruses type 16 and 18 in cervical carcinomas is related to the retention of E1/E2 genes. Int J Cancer 1994;56:640-5.
7. Berumen J, Unger ER, Casas L, Figueroa P. Amplification of human papillomavirus types 16 and 18 in invasive cervical cancer. Hum Pathol 1995;26:676-81.
8. Cullen AP, Reid R, Campion M. Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasm. J Virol 1991;65:606-12.
9. Fukushima M, Yamakawa Y, Shimano S, Hashimoto M, Sawada Y, Fujinaga K. The physical state of human papillomavirus 16 DNA in cervical carcinoma and cervical intraepithelial neoplasia. Cancer 1990;66:2155-61.
10. Galehouse D, Jenison E, Delucia A. Differences in the integration pattern and episomal forms of human papillomavirus type 16 DNA found within an invasive cervical neoplasm and its metastasis. Virology 1992;186:339-41.
11. Shirasawa H, Tomito Y, Kubota K, Kasai T, Sekiya S, Takamizwa H, Simizu B. Detection of human papillomavirus type 16 DNA and evidence for integration into the cell DNA in cervical dysplasia. J Gen Virol 1986;67:2011-25.
12. Boshart M, Gissman L, Ikenberg H, Kleinheinz A, Scheurlen W, zur Hausen H. A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer. EMBO J 1984;3:1151-7.
13. Popescu NC, DiPaolo JA. Integration of human papillomavirus 16 DNA and genomic rearrangements in immortalized human keratinocyte lines. Cancer Res 1990;50:1316-23.
14. Schwarz E, Freese UK, Gissman L, Mayer W, Roggenbuck B, Stremalu A, zur Hausen H. Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature 1985;314:111-4.
15. Stanley M, Sarkar S. Genetic changes in cervical carcinoma. Papillomavirus Report 1994;5:141-7.
16. Yiu KC, Huang DP, Chan MK, Ng AY, Chew EC, Wong FW, Lee JC. Integration of HPV-16 DNA in cervical carcinoma cell line CC3/CUHK3 and its xenografts. Anticancer Res 1990;10:917-22.
17. Romanczuk H, Howley PM. Disruption of either the E1 and E2 regulatory gene of human papillomavirus type 16 increases viral immortalization capacity. Proc Natl Acad Sci USA 1992;89:3159-363.
18. Clertant P, Seif I. A common function for polyoma virus large-T and papillomavirus E1 proteins. Nature 1984;311:276-9.
19. Bouvard V, Storey A, Pim D, Banks L. Characterization of the Human papillomavirus E2 protein: evidence of trans-activation and trans-repression in cervical keratinocytes. EMBO J 1994;13: 5451-9.
20. Stoler MH, Rhodes CR, Whitbeck A, Wolinsky SM, Chow LT, Broker TR. Human papillomavirus type 16 and 18 gene expression in cervical neoplasias. Hum Pathol 1992;23:117-28.
21. zur Hausen H, de Villiers EM. Human papillomavirus. Annu Rev Microbiol 1994;48:427-47.
22. Daniel B, Mukherjee G, Seshadri L, Vallikad E,. Krishna S. Changes in the physical state and expression of human papillomavirus type 16 in the progression of cervical intraepithelial neoplasia lesions analysed by PCR. J Gen Virol 1995;76:2589-93.
23. Swan DC, Vernon SC, Icenogle JP. Cellular proteins involved in papillomavirus induced transformation. Arch Virol 1994;138:105-15.
24. Chen CM, Shyu MP, Au LC, Chu HW, Cheng TK. Analysis of deletion of integrated human papillomavirus 16 sequence in cervical cancer: A rapid multiplex polymerase chain reaction approach. J Med Virol 1994;44:206-11.
25. Krajinovic M, Lazic J, Stanimirovic B, Diklic V, Savic, A. The E2 region of HPV 16 in relation to different types of cervical lesions. J Med Virol 1993;41:1-5.
26. Rakoczy P, Xu J, Higgins G, McKenzie J. Uniform deletions of HPV 16 DNA in the CaSki cell line and in cervical carcinomas:an analysis of the characteristyics of integrated multimeric HPV 16 genomes. Cancer J 1993;6:277-84.
27. Pettersson F. Annual report on the results of treatment in gynecologic cancer. FIGO 21. 1991. Editorial office: Radiumhemmet. S-104 01 Stockholm, Sweden.
28. Hagmar B, Johansson B, Kalantan M, Pettersson Z, Skyldberg B, Walaas L. The incidence of HPV in a Swedish series of invasive cervical carcinoma. Med Oncol Tumor Pharmacotheraphy 1992;9: 113-7.
29. Kristensen G, Karlsen F, Jenkins A, Kaern J, Abler VM, Trope CG. Human papillomavirus has no prognostic significance in cervical carcinoma. Eur J Cancer 1996;32A:1349-53.
30. Durst M, Gissmann L, Ikenberg H, zur Hausen H. A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc Natl Acad Sci USA 1983;80:3812-5.
31. Holm R, Karlsen F, Nesland JM. In situ hybridization with non-isotopic probes using different detection system. Mod Pathol 1992; 5:315-9.
32. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
33. Wagatsuma M, Hashimoto K, Matsukura T. Analysis of integrated human papillomavirus type 16 DNA in cervical cancers: Amplification of viral sequences together with cellular flanking sequences. J Virol 1990;64:813-21.
34. Beckman AM, Myerson D, Dalin JR, Kiviat NB, Fenoglio CM, McDougall JK. detection and localization of human papillomavirus DNA in human genital condylomas by in situ hybridization with biotinylated probes. J Med Virol 1985;16:265-73
35. Cooper K, Herrington CS, Graham AK, Evans MF, McGee JO'D. In situ human papillomavirus (HPV) genotyping of cervical intraepithelial neoplasia in South Africa and British patients: Evidence for putative HPV integration in vivo. J Clin Pathol 1991;44:400-5.
36. Cooper K, Herrington CS, Graham AK, Evans MF, McGee JO'D. In situ evidence for HPV 16, 18, 33 integration in cervical squamous cell cancer in Britain and South Africa. J Clin Pathol 1991; 44:406-9.
37. Cooper K, Herrington CS, Stickland JE, Evans MF, McGee JOD. Episomal and integrated human papillomavirus in cervical neoplasia shown by non-isotopic in situ hybridization. J Clin Pathol 1991;44:990-6.
38. Gorgoulis V, Rassidakis G, Karameris K, Giatromanolaki A, Barbatis C, Kittas C. Expression of p53 protein in laryngeal squamous cell carcinoma and dysplasia: possible correlation of human papillomavirus infection and clinicopathological findings. Virchows Arch 1994;425:481-9.
39. Kristiansen E, Jenkins A, Holm R. Coexistence of episomal and integrated HPV 16 DNA in squamous cell carcinoma of the cervix. J Clin Pathol 1994;47:253-6.
40. Wolber RA, Clement PB. In situ DNA hybridization of cervical small cell carcinoma and adenocarcinoma using biotin-labeled human papillomavirus probes. Mod Pathol 1991;4:96-100.
41. Choo KB, Cheung WF, Liew LN, Lee HH, Han SH. Presence of catenated human papillomavirus type 16 episomes in a cervical carcinoma cell line. J Virol 1989;63:782-.
42. Matsukura T, Kanda T, Furuno A. Cloning of monomeric human papillomavirus type 16 DNA integrated within cell DNA from cervical carcinoma. J Virol 1986;58:979-82.
43. Baker C, Phelps W, Lindgren V, Braun M, Gonda M, Howley P. Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines. J Virol 962-71.
44. El-awady MK, Kaplan JB, O'Brien SJ, Burk RD. Molecular analysis of integrated human papillomavirus 16 sequences in the cervical cancer cell. Virology 1987;159:389-98.
45. Choo KB, Pan CC, Han SH. Integration of human papillomavirus type 16 into cellular DNA of cervical carcinoma: Preferential deletion of the E2 gene and invariable retention of the long control region and the E6/E7 open reading frames. Virology 1987;161: 259-61.
46. Wilczynski SP, Pearlman L, Walker J. Identification of HPV 16 early genes retained in cervical carcinomas. Virology 1988;166: 624-7.
47. IARC monographs on the evaluation of carcinogenic risks to humans. Human Papillomavirus. 1995. WHO vol 94.
48. Belyavskyi M, Westerman M, Dimichele L, Wilson G. Perturbation of the host cell cycle and DNA replication by the Bovine papillomavirus replication protein E1. Virology 1996;219:206-9.
49. Muller F, Sapp M. Domains of the E1 protein of human papillomavirus type 33 involved in binding to the E2 protein. Virology 1996;219:247-56.
50. Winokur PL, McBride AA. Separation of the transcriptional activation and replication functions of the papillomavirus-1 E2 protein. EMBO J 1992;11:4111-8.
51. Tan SH, Gloss B, Bernard HU. During negative regulation of the human papillomavirus-16 E6 promoter, the viral E2 protein can displace Sp1 from a proximal promoter element. Nucl Acids Res 1992;20:251-6.
52. Demert C, Yaniv M, Thierry F. The E2 transcriptional repressor can compensate for SP1 activation of the Human Papillomavirus type 18 early promoter. J Virol 1994;68:7075-82.
53. Nasseri M, Gage JR, Lorincz A, Wettstein FO. Human papillomavirus type 16 immortalized cervical keratinocytes contain transcripts encoding E6, E7, and E2 initiated at the P97 promoter and express high levels of E7. Virology 1991;184:131-40.
54. Jeon S, Lambert PF. Integration of human papillomavirus type 16 DNA into the human genome leads to increased stability of E6 and E7 mRNAs: Implications for cervical carcinogenesis. Proc Natl Acad Sci USA 1995;92:1654-8.